Your search results.

pyramid3presponse_teaser.jpg

• Size: 7 kB
• Last Update: 01.24.2013

Label

• Size: 1 kB
• Last Update: 01.25.2013

General teasers

• Size: 1 kB
• Last Update: 01.22.2013

Million Heart Challenge Teaser

• Size: 1 kB
• Last Update: 12.11.2012

12-03-2012 Boehringer Ingelheim Announces Equine Research Awards

Researchers at two universities will be studying equine pigeon fever (Corynebacterium pseudotuberculosis) as recipients of the 2012 Advancement of Equine Research Awards, sponsored by Boehringer Ingelheim Vetmedica, Inc. (BIVI). Proposals by Roberta R. Pollock, Ph.D.

• Size: 7 kB
• Last Update: 12.11.2012

Prevention and treatment

The USDA has granted Boehringer Ingelheim Vetmedica, Inc., a conditional license for ERAV with: Equine Rhinitis A Vaccine – Killed Virus. It is available in 10 dose / 10 mL vials and pre-filled single dose syringes.

• Size: 3 kB
• Last Update: 01.8.2013

What is equine rhinitis A virus (ERAV)?

ERAV was originally classified as a part of the Rhinovirus genus and was previously known as equine rhinovirus 1. The first recognized serotype was reclassified in the genus Aphthovirus and is now called equine rhinitis A virus.

• Size: 10 kB
• Last Update: 12.12.2012

Equine respiratory disease

Equine respiratory disease is not only detrimental to the horse but also costly for horse owners. Between the treatment costs and days lost training, equine respiratory disease can quickly create an economic burden for the horse owner as well as reduce the quality of life for the horse.

• Size: 2 kB
• Last Update: 12.11.2012

Understanding equine rhinitis A virus

Could equine rhinitis A virus be affecting your respiratory health management program? Learn more about ERAV, including clinical signs and diagnosis.

• Size: 5 kB
• Last Update: 11.27.2012